This page is part of the FHIR Specification (v4.1.0: Release 4B Ballot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Encounter, Patient, Practitioner |
Raw JSON (canonical form + also see JSON Format Specification)
Request for Intravenous Chemotherapy (inpatient order) - Alemtuzumab - completed with multiple dosageInstruction lines
{ "resourceType": "MedicationRequest", "id": "medrx0317", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>identifier</b>: id: 12345689 (OFFICIAL)</p><p><b>status</b>: completed</p><p><b>intent</b>: order</p><p><b>medication</b>: <a> </a></p><blockquote><p><b>code</b>: <span>Alemtuzumab 10mg/ml (Lemtrada)</span></p></blockquote><p><b>subject</b>: <a>Donald Duck. Generated Summary: Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male</a></p><p><b>authoredOn</b>: 2015-01-15</p><p><b>requester</b>: <a>Patrick Pump. Generated Summary: id: 874635264 (OFFICIAL), id: 567IUI51C154 (USUAL); Simone Heps (OFFICIAL); Phone: 020556936, S.M.Heps@bmc.nl, Fax: 0205669283; gender: female; birthDate: 1971-11-07</a></p><p><b>reasonCode</b>: <span>Chronic Lymphoid Leukemia (disorder)</span></p><h3>DosageInstructions</h3><table><tr><td>-</td></tr><tr><td>*</td></tr><tr><td>*</td></tr><tr><td>*</td></tr></table></div>" }, "contained": [ { "resourceType": "Medication", "id": "med0303", "code": { "coding": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "code": "1594660", "display": "Alemtuzumab 10mg/ml (Lemtrada)" } ] } } ], "identifier": [ { "use": "official", "system": "http://www.bmc.nl/portal/prescriptions", "value": "12345689" } ], "status": "completed", "intent": "order", "medicationReference": { "reference": "#med0303" }, "subject": { "reference": "Patient/pat1", "display": "Donald Duck" }, "authoredOn": "2015-01-15", "requester": { "reference": "Practitioner/f007", "display": "Patrick Pump" }, "reasonCode": [ { "coding": [ { "system": "http://snomed.info/sct", "code": "92814006", "display": "Chronic Lymphoid Leukemia (disorder)" } ] } ], "dosageInstruction": [ { "sequence": 1, "text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk", "additionalInstruction": [ { "text": "Rapidly increase dose until tolerated" }, { "text": "Administer on alternate days" } ], "timing": { "repeat": { "duration": 12, "durationUnit": "wk", "frequency": 3, "period": 1, "periodUnit": "wk" } }, "route": { "coding": [ { "system": "http://snomed.info/sct", "code": "47625008", "display": "Intravenous route (qualifier value)" } ] }, "method": { "coding": [ { "system": "http://snomed.info/sct", "code": "422145002", "display": "Inject - dosing instruction imperative (qualifier value)" } ] }, "doseAndRate": [ { "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/dose-rate-type", "code": "ordered", "display": "Ordered" } ] }, "doseQuantity": { "value": 3, "unit": "mg", "system": "http://unitsofmeasure.org", "code": "mg" } } ] }, { "sequence": 2, "text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk", "additionalInstruction": [ { "text": "Rapidly increase dose until tolerated" }, { "text": "Administer on alternate days" } ], "timing": { "repeat": { "duration": 12, "durationUnit": "wk", "frequency": 3, "period": 1, "periodUnit": "wk" } }, "route": { "coding": [ { "system": "http://snomed.info/sct", "code": "47625008", "display": "Intravenous route (qualifier value)" } ] }, "method": { "coding": [ { "system": "http://snomed.info/sct", "code": "422145002", "display": "Inject - dosing instruction imperative (qualifier value)" } ] }, "doseAndRate": [ { "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/dose-rate-type", "code": "ordered", "display": "Ordered" } ] }, "doseQuantity": { "value": 10, "unit": "mg", "system": "http://unitsofmeasure.org", "code": "mg" } } ] }, { "sequence": 3, "text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk", "additionalInstruction": [ { "text": "Rapidly increase dose until tolerated" }, { "text": "Administer on alternate days" } ], "timing": { "repeat": { "duration": 12, "durationUnit": "wk", "frequency": 3, "period": 1, "periodUnit": "wk" } }, "route": { "coding": [ { "system": "http://snomed.info/sct", "code": "47625008", "display": "Intravenous route (qualifier value)" } ] }, "method": { "coding": [ { "system": "http://snomed.info/sct", "code": "422145002", "display": "Inject - dosing instruction imperative (qualifier value)" } ] }, "doseAndRate": [ { "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/dose-rate-type", "code": "ordered", "display": "Ordered" } ] }, "doseQuantity": { "value": 30, "unit": "mg", "system": "http://unitsofmeasure.org", "code": "mg" } } ] } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.